Medical device and MedTech insights, news, tips and more

Exact Sciences Signs Partnership with Pfizer to Market Cologuard Tests

August 23, 2018


Sales representatives of Pfizer Inc., the world’s largest pharmaceutical company, will join Exact Sciences Corp.’s sales representatives in selling the company’s non-invasive screening test for colorectal cancer to physicians and health systems under an agreement announced Wednesday.

Pfizer will make at least 625,000 sales calls a year for Exact Sciences under the agreement.

The two companies also committed to spending an additional $174 million, including $48 million this year, on marketing over four years.

The additional spending for advertising and other sales campaigns will be in addition to a baseline of $80 million a year that Exact Sciences spends on marketing for its Cologuard test.

“This partnership enables us, we believe, to permanently alter the trajectory of Cologuard,” Kevin Conroy, chairman and chief executive officer of Exact Sciences, said in a conference call with Wall Street analysts Wednesday morning.

Exact Sciences stock opened $10 a share, or 25 percent, higher Wednesday after the announcement. It closed at $65.32 a share, up $15.27, or 30.5 percent.

Read More at the Source: Exact Sciences signs agreement with Pfizer to market Cologuard tests

By: Guy Boulton

A Speciality Recruiting Firm Exclusively Servicing The Medical Device Industry

Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?
Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.